ADAMTS-13 mutant
- 专利权人:
- THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
- 发明人:
- Kenji Soejima
- 申请号：
- US14527856
- 公开号：
- US09109217B2
- 申请日:
- 2014.10.30
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
- 来源网站：
- 中国工程科技知识中心
